Clinical trial
Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin
NCT00441363 · VeroScience, Industry · Terminated
Key facts
| NCT number | NCT00441363 |
|---|---|
| Title | Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin |
| Official title | A Randomized, Double-Blind, Parallel-Group Trial to Assess the Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin in Patients With Type 2 Diabetes Mellitus |
| Lead sponsor | VeroScience, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | Bromocriptine Mesylate |
| Enrollment | 66 |
| Start date | Feb 1, 2005 |
| Primary completion | Feb 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Feb 28, 2007 |
| Last update posted | May 9, 2016 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: